Remove 2004 Remove Chemotherapy Remove Vaccines
article thumbnail

FDA Approves Meloxicam Injection For Moderate-to-Severe Pain in Adults

Pharmacy Times

December 21, 2004. PR Newswire. June 10, 2025. Accessed June 10, 2025. Meloxicam: Selective COX-2 inhibition in clinical practice. Seminars in Arthritis and Rheumatism.

FDA 73
article thumbnail

CHMP meeting highlights – July 2022

European Pharmaceutical Review

The CHMP also recommended an extension of the use of the smallpox vaccine Imvanex (live modified vaccinia virus Ankara) to include protecting adults from monkeypox and disease caused by vaccinia virus. Rubraca referral outcome. The CHMP also recommended approving a new manufacturing site for the finished product in Madrid, Spain.

Vaccines 105